AegirBio
Sales of Viraspec Covid-19 tests are being resumed
The ViraSpec Covid 19 antigen test was stopped on 10 November 2022 after an unannounced inspection at one of the Company's key suppliers. The identified non-conformities have now been addressed by the subcontractor wherefor the notified body has lifted the sales ban for the home test. The test for professional use, which the Company itself sales stopped pending the outcome of the notified body's review, is at the same time made available to the market. ViraSpec Covid 19 test is now available for the home testing market and for professional use.
This disclosure contains information that AegirBio is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 28-02-2023 10:57 CET.
| Datum | 2023-02-28, kl 10:57 |
| Källa | Cision |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.